Nuvation Bio Stock Price Prediction
| NUVB Stock | USD 2.69 0.01 0.37% |
Oversold Vs Overbought
59
Oversold | Overbought |
Nuvation Bio stock price prediction is an act of determining the future value of Nuvation Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Nuvation Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Nuvation Bio and does not consider all of the tangible or intangible factors available from Nuvation Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Nuvation Bio, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Nuvation Bio's stock price prediction:EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (0.35) | EPS Estimate Next Year (0.50) | Wall Street Target Price 5.9 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Nuvation Bio based on different types of headlines from major news networks to social media. The Nuvation stock price prediction module provides an analysis of price elasticity to changes in media outlook on Nuvation Bio over a specific investment horizon. Using Nuvation Bio hype-based prediction, you can estimate the value of Nuvation Bio from the perspective of Nuvation Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nuvation Bio using Nuvation Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nuvation using crowd psychology based on the activity and movement of Nuvation Bio's stock price.
Nuvation Bio Implied Volatility | 230.89 |
Nuvation Bio's implied volatility exposes the market's sentiment of Nuvation Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nuvation Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nuvation Bio stock will not fluctuate a lot when Nuvation Bio's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Nuvation Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Nuvation Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Nuvation because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nuvation Bio after-hype prediction price | USD 3.38 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nuvation |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nuvation Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nuvation Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Nuvation Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nuvation Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nuvation Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nuvation Bio Estimiated After-Hype Price Volatility
In the context of predicting Nuvation Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nuvation Bio's historical news coverage. Nuvation Bio's after-hype downside and upside margins for the prediction period are 0.17 and 11.34, respectively. We have considered Nuvation Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nuvation Bio is dangerous at this time. Analysis and calculation of next after-hype price of Nuvation Bio is based on 3 months time horizon.
Nuvation Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nuvation Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuvation Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nuvation Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.00 | 7.96 | 0.70 | 0.30 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.69 | 3.38 | 26.12 |
|
Nuvation Bio Hype Timeline
Nuvation Bio is now traded for 2.69. The entity has historical hype elasticity of 0.7, and average elasticity to hype of competition of -0.3. Nuvation is anticipated to increase in value after the next headline, with the price projected to jump to 3.38 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 26.12%, whereas the daily expected return is now at 1.0%. The volatility of related hype on Nuvation Bio is about 2615.96%, with the expected price after the next announcement by competition of 2.39. The company currently holds 4.01 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Nuvation Bio has a current ratio of 32.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Nuvation Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Nuvation Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nuvation Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nuvation to invest in growth at high rates of return. When we think about Nuvation Bio's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Nuvation Bio Basic Forecasting Models to cross-verify your projections.Nuvation Bio Related Hype Analysis
Having access to credible news sources related to Nuvation Bio's direct competition is more important than ever and may enhance your ability to predict Nuvation Bio's future price movements. Getting to know how Nuvation Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nuvation Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ASMB | Assembly Biosciences | (1.88) | 7 per month | 3.30 | 0.10 | 6.20 | (4.63) | 19.82 | |
| TIL | Instil Bio | (0.24) | 7 per month | 1.99 | 0.04 | 4.48 | (3.60) | 18.48 | |
| ACHL | Achilles Therapeutics PLC | (0.02) | 10 per month | 6.04 | 0 | 9.56 | (9.02) | 38.89 | |
| NXTC | NextCure | 0.15 | 4 per month | 4.85 | 0.09 | 8.13 | (7.93) | 32.17 | |
| NLTX | Neoleukin Therapeutics | (0.12) | 2 per month | 0.00 | (0.04) | 6.67 | (5.67) | 15.97 | |
| CTMX | CytomX Therapeutics | (0.10) | 10 per month | 3.82 | 0.02 | 8.16 | (5.80) | 50.71 | |
| SPRO | Spero Therapeutics | 0.08 | 9 per month | 3.29 | 0 | 4.82 | (5.59) | 16.20 |
Nuvation Bio Additional Predictive Modules
Most predictive techniques to examine Nuvation price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nuvation using various technical indicators. When you analyze Nuvation charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nuvation Bio Predictive Indicators
The successful prediction of Nuvation Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nuvation Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nuvation Bio based on analysis of Nuvation Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nuvation Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nuvation Bio's related companies. | 2023 | 2024 (projected) | Payables Turnover | 0.1 | 0.096 | Days Of Inventory On Hand | 9.3K | 8.3K |
Story Coverage note for Nuvation Bio
The number of cover stories for Nuvation Bio depends on current market conditions and Nuvation Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nuvation Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nuvation Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Nuvation Bio Short Properties
Nuvation Bio's future price predictability will typically decrease when Nuvation Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nuvation Bio often depends not only on the future outlook of the potential Nuvation Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nuvation Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 218.9 M | |
| Cash And Short Term Investments | 611.2 M |
Check out Nuvation Bio Basic Forecasting Models to cross-verify your projections. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Nuvation Stock analysis
When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Nuvation Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.35) | Return On Assets (0.1) | Return On Equity (0.12) |
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.